Bile Duct Cancer, also known as bile duct carcinoma, is related to cholangiocarcinoma and adenosquamous bile duct carcinoma, and has symptoms including abdominal pain, constipation and diarrhea. An important gene associated with Bile Duct Cancer is CEACAM5 (CEA Cell Adhesion Molecule 5), and among its related pathways/superpathways are Infectious disease and ERK Signaling. The drugs Celecoxib and Arginine have been mentioned in the context of this disorder. Affiliated tissues include liver and small intestine, and related phenotypes are Decreased viability and Increased cell migration